Navigation Links
Drug discovery programs boosted
Date:12/2/2010

Dec 03, 2010, Seoul, S. Korea Institut Pasteur Korea (IP-K) has signed an agreement with sanofi-aventis Research & Development of Toulouse, France to continue research on the identification of new medicines.

The partnership, extending an agreement drawn up in the fall of 2009, illustrates the value of IP-K's PhenomicScreen to the pharmaceutical industry. The technology platform will be used to pinpoint active, non-toxic agents in sanofi-aventis' proprietary chemical compound library.

The high-throughput, high-content visual screening approach of PhenomicScreen is well suited to identifying lead compounds. Dr. Priscille Brodin of IP-K explains that "Our phenotypic approach does not rely on a predefined target, but rather simultaneously selects both chemical compounds and an unknown cellular target solely by the clearly discernible effect on the disease model". The advantage, according to IP-K's Dr. Jonathan Cechetto, is that "The process has the ability to select novel targets, and only those which are functionally significant in the disease process".

Commenting on the new agreement with sanofi-aventis, Laurent Fraisse, director of infectious diseases research said "Over the past year the collaboration has made important strides in identifying potential new drugs, and we are pleased to extend our agreement with IP-K."

Center Director of Core Technologies of Institut Pasteur Korea Dr. Veronica Soloveva believes that the agreement is a vindication of the institute's innovative approach to drug discovery. "Phenomic technology increases the accuracy and speed of drug discovery", she said, "And we are delighted to be working with sanofi-aventis to accelerate their identification of new compounds".


'/>"/>

Contact: Jean Kim
babunn@ip-korea.org
82-318-018-8041
Institut Pasteur Korea
Source:Eurekalert

Page: 1

Related biology news :

1. Chemical equator discovery will aid pollution mapping
2. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
3. Groundbreaking discovery may lead to stronger antibiotics
4. Discovery of natural compounds that could slow blood vessel growth
5. Nanoscopic screening process to speed drug discovery
6. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
7. New $11 million center to speed production of new compounds for drug discovery
8. Discovery of giant roaming deep sea protist provides new perspective on animal evolution
9. New discovery may enhance MRI scans, lead to portable MRI machines
10. Kidney function discovery sheds light on genetic complexity of disease
11. Discovery of new gene associated with diabetes risk suggests link with body clock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... MD (May 18, 2013) The AGA Research Foundation ... into the relationship between the gut microbiota, one of ... and disease. , The AGA Research Awards Panel ... from Massachusetts General Hospital and Harvard Medical School, Boston, ... recipient. Dr. Chan will receive $25,000 of funding, commencing ...
(Date:5/17/2013)... celebrate the science and technology of the region ... the inaugural Atlanta Science Festival, March 22-29, 2014. ... corporations, K-12 schools and universities, the festival will ... and adults at venues across the city. Learn ... annual Atlanta Science Festival is a collaboration of ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2First Atlanta Science Festival set for 2014 2
... Brook University Medical Center in New York have confirmed that ... and not a descendant of healthy humans dwarfed by disease. ... female specimen, researchers determined the "hobbit" to be a distinct ... Details of the study appear in the December issue ...
... advance with overtones of Star Trek phasers and other sci-fi ... internal on-off "switch" that paralyzes animals when exposed to a ... the light is turned off. When exposed to ordinary light, ... in the Journal of the American Chemical Society ...
... using human saliva to tell whether those stiff joints, memory ... red flags for disease, scientists are describing how the protein ... could lead to a simple, noninvasive test for better diagnosing ... a report in ACS, Journal of Proteome Research , ...
Cached Biology News:'Hobbits' are a new human species -- according to the statistical analysis of fossils 2
(Date:5/16/2013)... 2013 On average, developing a new ... billion dollars. Despite this investment, less than 10% of ... is your clinical trial design optimally structured to balance ... , Dr. Frederic Sax, Global Head of the Center ... of data, information and technology in upfront clinical trial ...
(Date:5/16/2013)... , May 16, 2013 /PRNewswire/ ... market research report is available in ... Diagnostic Cardiac Biomarkers for Acute Coronary ... Forecasts http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... for Acute Coronary Syndromes - APAC ...
(Date:5/16/2013)... May 16, 2013 DNA Genotek, a leading ... for Africa’, a sponsorship program in conjunction with the African ... to improve access and reduce the cost of DNA ... as the Human Heredity and Health in Africa (H3 Africa) ... , The aim of the AfSHG is to ...
(Date:5/16/2013)... A number of residents in an apartment complex ... from abcactionnews.com, it was no thanks to the infestation of ... recommended to the management and everyone else suffering from the ... the public to try samples of it to prove it ... 11, 2013 determined that the complex invaded by ...
Breaking Biology Technology:Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help 2Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help 3
... 2011 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) ... of 6,700,000 shares of its common stock at a price ... is expected to close on or around Wednesday, April 13, ... the sole book-running manager in this offering and Sangamo has ...
... RICHMOND, Calif., April 7, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... to sell 6,700,000 shares of its common stock pursuant to ... Barclays Capital Inc. is the sole book-running manager in this ... day option to purchase up to 1,005,000 additional shares. ...
... The Center for Business Intelligence (CBI) announced today that ... in support of the relief efforts in Japan following a ... the fund while the organization matched employee donations. ... employees have displayed to help a nation in a desperate ...
Cached Biology Technology:Sangamo Announces Pricing of Public Offering of Common Stock 2Sangamo Announces Pricing of Public Offering of Common Stock 3Sangamo Announces Public Offering of Common Stock 2Sangamo Announces Public Offering of Common Stock 3The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2
... are macroporous polystyrene beads for hydrophobic interaction ... for adsorbing organics of molecular weight less ... are useful for the adsorption of nonpolar ... the removal of detergents such as Triton ...
MAb to Catenin beta, N-terminal (exon 2) Catenin, beta, N-terminal (exon 2)...
... Phosphatase 2 (LPP2) fractionated ... solution Solution in ... 0.08% sodium azide. unique ... human LPP2 protein. The ...
Rabbit polyclonal to Retinoic Acid Receptor beta 2 ( Abpromise for all tested applications). entrezGeneID: 5915...
Biology Products: